About Avenda Health
Avenda Health is a healthcare AI company dedicated to revolutionizing personalized prostate cancer care. Their flagship product, Unfold AI (formerly iQuest), is an FDA-cleared, multi-modal AI decision support platform that provides physicians with precise, patient-specific 3D maps of prostate cancer. This technology integrates existing diagnostic information, such as imaging, pathology, biomarkers, and clinical data, with deep-learning algorithms to reveal the full extent of the cancer, including microscopic ‘tentacles’ often missed by traditional imaging like MRI.
For physicians, Unfold AI enhances the ability to identify cancer extent by a significant margin, improving diagnostic accuracy and confidence in treatment planning. The platform supports various treatment options, including focal therapy (such as laser ablation with their FocalPoint System), active surveillance, and decision-making for whole-gland treatments. By enabling more precise interventions that target only cancerous tissue while sparing healthy surrounding tissue, Avenda Health aims to improve patient outcomes, preserve quality of life by minimizing side effects (like urinary and sexual dysfunction), and establish a new standard of care in prostate cancer management.
Focus Areas
Business Intelligence
| Key Investors | VCapital, Plug & Play Ventures, Wealthing VC Club, SCP Ventures |
| Partnerships | BioscienceLA, EDAP TMS SA, Urology Associates (PrecisionPoint®) |
| Technology | Unfold AI (AI-powered 3D cancer mapping platform, formerly iQuest), FocalPoint System (focal laser ablation device), deep learning algorithms, cloud-based clinical decision support |
| FDA Clearances | 2 cleared products (estimated) |
What Physicians Need to Know
For physicians, Avenda Health's Unfold AI offers a 'superhuman' ability to accurately identify the extent of prostate cancer, improving diagnostic capabilities by up to 45 times and achieving 84% accuracy in predicting cancer extent. This leads to more precise and personalized treatment planning, allowing for tailored interventions that can preserve patient quality of life by sparing healthy tissue. The platform provides unprecedented confidence in care decisions and supports the shift towards less invasive, in-office focal therapy options. Furthermore, the inclusion of Unfold AI in the AMA's 2024 CPT code set as a Category III code means it is now billable by insurance, improving patient access to this advanced personalized prostate cancer care.
Avenda Health's Unfold AI platform is designed to integrate with a patient's existing diagnostic data, including MRI images, biopsy information, pathology reports, and biomarkers. They have also established collaborations to integrate Unfold AI with other technologies, such as the PrecisionPointu00ae Transperineal Access System for safer and more precise biopsies, and with EDAP TMS's Focal Oneu00ae robotic HIFU platform for AI-assisted focal therapy procedures.
What the Web Says
Avenda Health is an AI healthcare company focused on personalized prostate cancer care. Their flagship product, Unfold AI, is an FDA-cleared platform that uses artificial intelligence to map prostate tumors in 3D, aiming to improve treatment decisions and outcomes. Studies have shown Unfold AI to be significantly more accurate than standard methods in identifying cancer extent, leading to a higher likelihood of patients being cancer-free. While there is extensive information on their product's efficacy and potential, public reviews specifically from platforms like G2, Glassdoor, Capterra, or Reddit for Avenda Health as a company or employer are limited.
Overall: PositiveStrengths
- Unfold AI significantly improves the accuracy of identifying prostate cancer extent compared to standard methods.
- The technology aids physicians in surgical planning and treatment decision-making.
- Unfold AI has been shown to reduce the underestimation of cancer extent and increase negative margin rates.
- The platform has the potential to enable more patient-specific treatment for various cancers beyond prostate cancer.
- Avenda Health's technology has received FDA clearance.
- The company's approach aims to improve outcomes for men, reduce healthcare costs, and preserve quality of life.
Limitations
- Unfold AI is a new technology and is not yet fully covered by insurance.
- The study cases for Unfold AI were derived from a single institution, which may not represent performance in broader populations.
- The ground truth for studies was set by a single expert pathologist, lacking a method to address observer dependency.
- Specific employer or product reviews on major platforms like G2, Glassdoor, Capterra, or Reddit are not readily available.
- The average annual salary for employees at Avenda Health Inc. is an estimation and does not originate from the company's factual payroll records or survey data.
Based on reviews from: Optics.org, BioWorld, AuntMinnie, Avenda Health Official Website, PR Newswire, SimplyHired, Vertex AI Search
Last updated: 2026-07-17
Videos
News, demos, and interviews about Avenda Health.
Videos load interactively. If none appear, search YouTube for Avenda Health →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Avenda Health.
Comparisons
Related Companies
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]
MedTalk AI is an Australian-based healthcare AI company focused on streamlining clinical documentation for physicians and other healthcare professionals. The company’s flagship product is an ambient AI medical scribe that listens to real clinical conversations and converts them into structured, accurate notes in real-time. This technology aims to free clinicians from the burden of manual […]
allergoSMART is a healthcare AI company that offers the world’s first AI-based complete solution for personalized mite allergen avoidance. The company’s system, allergoSMART, provides a unique AI digital solution for individuals with dust mite allergies, combining targeted prevention and treatment through comprehensive home environment optimization. [3] It integrates symptom tracking, telemedicine, and air purification into […]